Total Live Articles: 471

Migraine

NICE clinical guideline [CG150] Headaches in over 12s: diagnosis and management. Last updated: Jun 2025.

NICE CKS Migraine. Last revised: Feb 2024.

Migraine

Migraine is a common primary headache disorder, meaning it is not caused by another underlying condition.

This updated UKMLA guide to migraine is based on NICE CG150, which covers types (including migraine without aura, migraine with aura, hemiplegic migraine), causes, risk factors, symptoms, diagnosis, and management.

Causes and Risk Factors

Migraine is considered to be a disorder of neuronal excitability involving multiple neural networks and anatomical regions in the brain

  • The exact underlying cause and pathophysiology are not fully understood, involving a combination of genetic, environmental and lifestyle factors
  • Headache in migraine is thought to be a result of neurogenic inflammation of the CN V1 (trigeminal nerve 1st division), altering the way the brain processes pain, so non-painful stimuli may be interpreted as painful

Risk factors for developing migraine:

  • Females
  • Family history of migraine
  • Low socio-economic status
  • Allergies or asthma
  • Hypothyroidism

Risk factors associated with chronic migraine:

  • High frequency episodic migraine
  • Overuse of acute migraine medications
  • Excessive caffeine intake
  • Obesity
  • Snoring and sleep disorders
  • Comorbid complications (e.g. head injury, pain disorders, anxiety, depression)
  • Major life events (e.g. divorce, marriage, loss of job)

Triggers

Common triggers:

  • Sleep disturbances
  • Excessive caffeine intake
  • Stress
  • Lack of exercise
  • Irregular or missed meals
  • Menstruation

However, it is not always possible to identify a trigger

Complications

Possible acute complications:

  • Status migrainosus – migraine attack lasting for >72 hours
  • Migrainous infarction – aura symptoms lasting >60 min + ischaemic infarct on neuroimaging
  • Migraine aura-triggered seizure

Migraine itself increases the risk of ischaemic stroke (and possibly also haemorrhagic stroke).

Long-term complications:

  • Medication-overuse headache – migraine is the most common underlying primary headache disorder associated with medication overuse
  • Reduced functional ability and QoL
  • Progression to chronic migraine
  • Depression
  • ↑ Complications in pregnancy (more likely to experience pre-eclampsia, cerebral venous sinus thrombosis, preterm birth, low birth weight baby)

Diagnosis

Clinical Features

Typical Migraine Features

Typical migraine often refers to:

  • Migraine with aura, and
  • Migraine without aura

Migraine attacks are often described in several phases, although not every patient experiences every phase.

Typical phases in adults:

Phase (in order) Clinical features
Prodromal phase Possible symptoms:

  • Fatigue
  • Poor concentration
  • Neck stiffness
  • Yawning
  • Mood changes
  • Food cravings
Aura Aura is characterised by transient focal neurological symptoms that usually precede the headache (or may accompany the headache)

  • Aura is pathognomonic of migraine but only seen in 15-30% of patients with migraine
  • Aura develops over at least 5 min and lasts 5-60 min
  • An aura should be fully reversible

Typical aura symptoms:

  • Visual symptoms (perceived in both eyes) – most common
    • Positive symptoms: flickering lights, spots, scintillating zig-zag lines (fortification spectrum)
    • Negative symptoms: partial loss of vision
  • Sensory symptoms – numbness, paraesthesia (typically begins in the hands or mouth and slowly spreads up the arm or across one side of the face)
  • Speech disturbance
Headache Typical headache feature:

  • Location: unilateral (more common than bilateral)
    • Typically hemicranium at the frontotemporal and ocular region
  • Pain character: pulsating or throbbing
  • Duration: 4-72 hours

The headache is typically aggravated by, or causes avoidance of, ADLs

Associated features:

  • Nausea and/or vomiting
  • Photophobia (sensitivity to light)
  • Phonophobia (sensitivity to sound)

Patients typically prefer to lie still in a dark, quiet room

Postdromal phase “Migraine hangover”:

  • Fatigue
  • Brain fog
  • Mood changes
  • Residual sensitivity to light or sound

Menstrual-related migraine is a specific predictable subtype of typical migraine, characterised by:

  • Migraine occurring predominantly between 2 days before and 3 days after the start of menstruation for at least 2 out of 3 consecutive menstrual cycles

Migraine in the paediatric population has slightly different presentations: [Ref1][Ref2]

  • Location
    • Often bilateral (more commonly unilateral in adults)
    • Frequently frontal or temporal rather than hemicranial
  • Character
    • Pounding or throbbing, but in younger children may be less distinctly pulsatile
  • Duration
    • Usually shorter
  • Associated symptoms
    • More likely to experience prominent gastrointestinal symptoms, especially vomiting and nausea

Migraine Subtypes / Variants

The following are often considered as “atypical migraines”:

Migraine subtype / variant Clinical features
Typical aura without headache (“silent migraine”) Occurs in older people in particular:

  • Typical aura symptoms (visual / sensory / speech)
  • Followed by NO headache

The absence of headache makes excluding a TIA and other causes difficult.

Aura develops over at least 5 min and lasts 5-60 min and should be fully reversible

  • Visual symptoms – most common
    • Positive symptoms: flickering lights, spots or lines, scintillating, zig-zagging lines (fortification spectrum)
    • Negative symptoms: partial loss of vision
  • Sensory symptoms – numbness, paraesthesia (typically begins in the hands or mouth and slowly spreads up the arm or across one side of the face)
  • Speech disturbance
Hemiplegic migraine Motor aura symptoms:

  • Reversible unilateral weakness
  • Often with typical aura symptoms (visual / sensory / speech)

Usually a typical migraine headache follows or overlaps with the aura

Hemiplegic migraine is a classic TIA / stroke mimic.

Migraine with brainstem aura Brainstem aura symptoms:

  • Dysarthria
  • Vertigo
  • Tinnitus
  • Diplopia
  • Ataxia
  • Reduced consciousness

There should be NO motor weakness or retinal symptoms.

Usually a typical migraine headache follows or overlaps with the aura

Retinal migraine Aura in retinal migraine:

  • Monoocular visual disturbances
  • Visual disturbances should disappear when the affected eye is covered

This contrasts with a typical visual aura, which is usually a cortical visual-field phenomenon, often perceived through both eyes and sometimes still visible with eyes closed

Patients with any of the following atypical neurological symptoms should be considered for urgent specialist assessment and/or hospital admission, depending on clinical judgement:

  • Motor weakness
  • Double vision
  • Visual symptoms affecting only one eye
  • Poor balance / ataxia
  • Reduced level of consciousness

Headache Red Flags

If the headache has ANY of the following red flags, consider the need for further investigations and/or referral:

Category Red Flag Explanation
Infection / inflammation Worsening headache with fever Suggests possible central nervous system infection (e.g., meningitis, encephalitis) or inflammatory disease.
Symptoms suggestive of giant cell arteritis (e.g., jaw claudication, age >50, visual symptoms) Points to vasculitis with risk of vision loss or stroke.
Immunocompromised status (HIV, immunosuppressive drugs) Increases risk for opportunistic infections and neoplastic processes.
Vascular / haemorrhagic Sudden-onset headache reaching maximum intensity within 5 minutes (thunderclap) Characteristic of subarachnoid haemorrhage, reversible cerebral vasoconstriction syndrome, or other acute vascular events.
New-onset neurological deficit May indicate stroke, intracranial mass, encephalitis, or other structural or metabolic brain disorders.
New cognitive dysfunction, personality change, or impaired level of consciousness Suggests stroke, intracranial mass, encephalitis, or other significant brain pathology.
Raised ICP / structural Headache triggered by cough, valsalva manoeuvre, sneeze, or exercise Can be a sign of increased intracranial pressure (e.g., due to intracranial mass).
Vomiting without other clear cause May reflect increased intracranial pressure or mass effect.
Substantial change in headache characteristics May signal a new secondary process, such as neoplasm or infection.
Intracranial hypotension Orthostatic headache Typical of intracranial hypotension, often due to CSF leak.
Trauma-related Recent head trauma (within 3 months) Raises concern for traumatic intracranial haemorrhage (e.g. subdural haematoma).
Oncology-related Age <20 with history of malignancy Raises suspicion for metastatic or recurrent disease affecting the CNS.
History of malignancy known to metastasise to the brain Increases risk for intracranial metastases.
Ophthalmic emergencies Symptoms/signs of acute narrow-angle glaucoma (painful red eye, visual loss) Requires urgent ophthalmological evaluation.

If there is a new-onset headache with ANY of the following, consider the need for further investigations and/or referral:

  • Immunocompromised (e.g. HIV, use of immunosuppressive drugs)
  • <20 y/o + history of malignancy
  • History of malignancy known to metastasise to the brain
  • Vomiting without other obvious causes

Investigation and Diagnosis

Migraine, like other primary headache disorders, is primarily a clinical diagnosis.

Consider using a headache diary for at least 8 weeks to help diagnose primary headaches. The patient should record the following:

  • Frequency, duration and severity of headaches
  • Any associated symptoms
  • Possible precipitants
  • Relationship of headaches to menstruation
  • All medications taken to relieve headaches

Do NOT refer people diagnosed with tension‑type headache, migraine, cluster headache or medication-overuse headache for neuroimaging solely for reassurance.

Diagnostic Criteria

Migraine is primarily a clinical diagnosis

Diagnostic criteria (for typical migraine):

Migraine type Diagnostic criteria
Migraine without aura At least 5 attacks fulfilling the following criteria:

  • Headache lasting 4–72 hours in adults or 2–72 hours in adolescents.
  • Headache with at least 2 of the following characteristics:
    • Unilateral location (more commonly bilateral in children)
    • Pulsating quality (may be described as ‘throbbing’ or ‘banging’ in young people)
    • Moderate or severe pain intensity
    • Aggravation by, or causing avoidance of, routine activities of daily life (e.g. walking or climbing stairs)
  • Headache with at least 1 of the following associated symptoms:
    • Nausea and/or vomiting
    • Photophobia and phonophobia
  • Headache must not be better accounted for by another diagnosis
Migraine with aura At least 2 attacks fulfilling the following criteria:

  • At least 1 fully reversible typical aura symptom:
    • Visual symptoms such as fortification spectra
    • Sensory symptoms such as unilateral paraesthesiae or numbness
    • Speech and/or language symptoms such as dysphasia
  • At least 3 of the following
    • At least one aura symptom spreads gradually over at least 5 minutes
    • Two or more aura symptoms occur in succession
    • Each individual aura symptom lasts 5-60 minutes
    • At least one aura symptom is unilateral
    • At least one aura symptom is positive (such as scintillations or paraesthesiae)
    • The aura is accompanied, or followed within 60 minutes, by headache.
  • Headache must not be better accounted for by another diagnosis

Frequency of migraine attack:

  • Median: 1-2 attacks per month
  • Episodic migraine: migraine occurs on <15 days per month
  • Chronic migraine: occurring ≥15 days per month for >3 months

Management

Adults

Acute Management

Educate patients about prescribed acute treatment:

  • Take the medication early while pain is mild
  • If using a triptan for migraine with aura, it should be taken at the start of the headache, not at the start of the aura (unless the aura and headache start simultaneously)
  • If acute treatment has not been effective within 2 hours, it is unlikely to work for that migraine attack (consider higher doses or alternative treatment or combination treatment)

Restrict acute medication use to a maximum of 2 days per week to avoid the risk of developing medication-overuse headache.

Choice of acute drug treatment:

1st line Combination therapy of:

  • Oral triptan (1st line: sumatriptan) PLUS
  • Oral NSAID OR paracetamol

If the person prefers taking 1 drug → monotherapy of oral paracetamol / aspirin (900 mg) / NSAID / triptan

2nd line Consider non-oral medications:

  • Prochlorperazine (buccal), or
  • Metoclopramide (IM / IV – mainly used in hospital setting)

Consider adding non-oral NSAID (e.g. rectal diclofenac) or triptan (e.g. nasal spray) if they have not been tried

3rd line Oral rimegepant (CGRP inhibitor), if

  • At least 2 triptans were tried and not effective, or
  • Triptans were inappropriate, and NSAIDs + paracetamol were not effective

Consider an antiemetic in addition to other acute treatment for migraine, even in the absence of nausea and vomiting

Do NOT offer ergots or opioids.

Long-Term Management

Management aspect Description / recommendation
Conservative / general management
  • Advise that although migraine cannot be cured, it can be effectively managed in most cases
  • Keeping a headache diary can help identify triggers and monitor the effectiveness of treatment
  • Avoid known triggers and advise on lifestyle changes, such as
    • Stress management
    • Good sleep hygiene
    • Adequate hydration
    • Regular meals
    • Exercise
    • Mindfulness or relaxation techniques
    • Maintain a healthy weight

Ensure that women who have migraine with aura are NOT using COCP, which is contraindicated.

Preventive / prophylactic treatment Do NOT routinely offer preventive / prophylactic treatment.

Only consider if ANY of the following:

  • Migraine attacks have a significant impact on QoL and daily function
  • Acute treatments are ineffective or contraindicated
  • At risk of medication-overuse headache due to frequent use of acute drugs
    • It is essential to rule out medication overuse headache before preventive treatment is initiated

If migraine is of an uncommon type (for example, hemiplegic migraine, or migraine with prolonged aura) — refer or seek expert advice before considering preventative medication.

Choice of preventive / prophylactic treatment:

  • 1st line (any of the following):
    • Propranolol (avoid in asthma and those with depression due to an increased risk of using it for self-harm)
    • Topiramate (contraindicated in pregnancy and avoid in women of childbearing age)
    • Amitriptyline​​​​​
  • 2nd line (only if all 3 1st line options are not appropriate): acupuncture over 5-8 weeks for up to 10 sessions
  • 3rd line options (only to be considered if at least 3 preventive medicines are ineffective or not appropriate):
    • CGRP inhibitors – in adults with ≥4 migraine days per month
    • IM botulinum toxin type A

Riboflavin (vitamin B2) may be effective in reducing migraine frequency and intensity for some people

Treatments may take up to 6 weeks to provide a benefit

Do not offer gabapentin for the prophylactic treatment of migraine

Menstrual-Related Migraine

If not responding adequately to standard acute treatment, consider frovatriptan or zolmitriptan on the days migraine is expected

Ensure that women who have migraine with aura are NOT using COCP, which is contraindicated.

Young People (12-17 y/o)

Acute management:

  • 1st line: monotherapy of paracetamol or NSAID 
  • 2nd line: nasal triptan (oral triptan is not licensed for use <18 y/o)
  • 3rd line: combination therapy of nasal triptan + paracetamol / NSAID

Preventive / prophylactic treatment should only be started by a specialist

Do NOT offer aspirin in those <16 yo due to risk of Reye’s syndrome.

Pregnant / Breastfeeding Women

Acute management:

  • 1st line: non-pharmacological measures (e.g. relaxation technique, CBT, avoidance of triggers)
  • 2nd line: paracetamol
  • 3rd line: ibuprofen (if <20 weeks gestation) or triptan 

Metoclopramide and prochlorperazine can be used as short-term treatment options for nausea and vomiting in pregnancy.

Preventive / prophylactic treatment should only be started by a specialist

Do NOT offer aspirin (or opioids) for the acute management of migraines in pregnancy or breastfeeding.

References


Related Articles

Tension-Type Headache

Cluster Headache

Stroke (Overview)

Transient Ischaemic Attack (TIA)

Subarachnoid haemorrhage (SAH)

Raised Intracranial Pressure (ICP)

Acute Angle-Closure Glaucoma

Share Your Feedback Below

Disclaimer

We’re actively expanding Guideline Genius to cover the full UKMLA content map. Therefore, you may notice some conditions not uploaded yet, or articles that currently focus on diagnosis and management for now.

We are also continuously reviewing and updating existing content to ensure accuracy and alignment with current guidelines. Some earlier articles are undergoing revision as part of this process. Once all content has been fully reviewed, this will be clearly communicated on the platform.

For updates, follow us on Instagram @guidelinegenius.

We welcome any feedback or suggestions via the anonymous feedback box at the bottom of each article and will do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD

Stay Updated withGuideline Genius

Sign up to be notified when our newsletter launches, covering major guideline updates, article updates, and future UKMLA resources.